Referenser

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464.

  2. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005(3):Cd000247.

  3. Hedin K, Bieber L, Lindh M, Sundqvist M. The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium necrophorum is commonly found. Clin Microbiol Infect. 2015;21(3):263.e1-7.

  4. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010;126(3):e557-64.

  5. Oliver J, Malliya Wadu E, Pierse N, Moreland NJ, Williamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis. PLoS Negl Trop Dis. 2018;12(3):e0006335.

  6. FB OL, Alves KB, Barros RR. Prevalence and long-term persistence of beta-haemolytic streptococci throat carriage among children and young adults. J Med Microbiol. 2019;68(10):1526-33.

  7. Lönnqvist E, Gröndahl-Yli-Hannuksela K, Loimaranta V, Vuopio J. Low rate of asymptomatic carriage and salivary immunoglobulin A response to Group A Streptococci in the healthy adult population in Finland. Med Microbiol Immunol. 2022;211(5-6):261-7.

  8. Tell D, Tyrstrup M, Edlund C, Rystedt K, Skoog Ståhlgren G, Sundvall PD, et al. Clinical course of pharyngotonsillitis with group A streptococcus treated with different penicillin V strategies, divided in groups of Centor Score 3 and 4: a prospective study in primary care. BMC Infect Dis. 2022;22(1):840.

  9. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12(12):Cd000023.

  10. Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. Bmj. 2000;320(7228):150-4.

  11. Pallon J, Sundqvist M, Hedin K. A 2-year follow-up study of patients with pharyngotonsillitis. BMC Infect Dis. 2018;18(1):3.

  12. Pallon J, Sundqvist M, Rööst M, Hedin K. Association between bacterial finding, antibiotic treatment and clinical course in patients with pharyngotonsillitis: a registry-based study in primary healthcare in Sweden. BMC Infect Dis. 2021;21(1):779.

  13. ePed Erfarenhets & Evidensbaserad Databas för Barnläkemedel. Stockholm [citerad 2024-06-12].

  14. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;6(6):Cd000245.

  15. Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis. 2013;13(2):123-9.

  16. Läkemedelsverket. Läkemedel vid infektion med respiratoriskt syncytievirus (RSV‍) – behandlings­rekommendation  [updated 2024-10-03]. Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/lakemedel-vid-infektion-med-respiratoriskt-syncytievirus-rsv-behandlingsrekommendation

  17. Folkhälksomyndigheten. Rekommendationer för att förebygga kikhosta hos spädbarn  [updated 2016-08-25]. Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-for-att-forebygga-kikhosta-hos-spadbarn/

  18. Läkemedelsverket. Antibiotika till gravida och ammande – behandlings­rekommendation  [updated 2023-09-20]. Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/antibiotika-till-gravida-och-ammande-behandlingsrekommendation

  19. Folkhälsomyndigheten. Behandlingsrekommendationer för vanliga infektioner i öppenvård  [updated 2023-10-30]. Available from: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/b/behandlingsrekommendationer-for-vanliga-infektioner-i-oppenvard/

  20. Läkemedelsverket. Behandling och profylax vid influensa – behandlings‌‌­rekommendation  [updated 2024-12-10]. Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/behandling-och-profylax-vid-influensa-behandlingsrekommendation

  21. Läkemedelsverket. Vetenskapliga underlag: Antibiotika till gravida och ammande. Uppsala; 2023.

  22. Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162-77.

  23. Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(8):e2228008.

  24. Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol. 2023;21(3):147-61.

  25. Tyrstrup M, Beckman A, Mölstad S, Engström S, Lannering C, Melander E, et al. Reduction in antibiotic prescribing for respiratory tract infections in Swedish primary care- a retrospective study of electronic patient records. BMC Infect Dis. 2016;16(1):709.

  26. Aviles-Solis JC, Jácome C, Davidsen A, Einarsen R, Vanbelle S, Pasterkamp H, et al. Prevalence and clinical associations of wheezes and crackles in the general population: the Tromsø study. BMC Pulm Med. 2019;19(1):173.

  27. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82.

  28. Henriksen DP, Pottegård A, Laursen CB, Jensen TG, Hallas J, Pedersen C, et al. Risk factors for hospitalization due to community-acquired sepsis - a population-based case-control study. PLoS One. 2015;10(4):e0124838.

  29. Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, et al. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med. 2004;116(8):529-35.

  30. Moberg AB, Kling M, Paues J, Fransson SG, Falk M. Use of chest X-ray in the assessment of community acquired pneumonia in primary care - an intervention study. Scand J Prim Health Care. 2020;38(3):323-9.

  31. Gentilotti E, De Nardo P, Cremonini E, Górska A, Mazzaferri F, Canziani LM, et al. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(1):13-22.

  32. Andersen CA, Frandsen AK, Valentiner-Branth C, Lykkegaard J, Løkkegaard T, Thomsen JL, et al. Introducing point-of-care ultrasound in Danish general practice-elucidating the use through a medical audit. Fam Pract. 2021;38(2):80-7.

  33. Rhedin S, Kvist B, Caffrey Osvald E, Karte G, Smew AI, Nauclér P, et al. Penicillin V versus amoxicillin for pneumonia in children-a Swedish nationwide emulated target trial. Clin Microbiol Infect. 2024;30(11):1418-25.

  34. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17(11):986-91.

  35. Leventhal JM. Clinical predictors of pneumonia as a guide to ordering chest roentgenograms. Clin Pediatr (Phila). 1982;21(12):730-4.

  36. Shah SN, Bachur RG, Simel DL, Neuman MI. Does This Child Have Pneumonia?: The Rational Clinical Examination Systematic Review. Jama. 2017;318(5):462-71.

  37. Incorrect Data in the Statistical Methods Section. Jama. 2017;318(13):1284.

  38. McCracken GH, Jr. Diagnosis and management of pneumonia in children. Pediatr Infect Dis J. 2000;19(9):924-8.

  39. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1(1):Cd004875.